Title:
TRICYCLIC COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/013083
Kind Code:
A1
Abstract:
Disclosed herein is a tricyclic compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.
Inventors:
LI JING (CN)
WANG ZHIWEI (CN)
XU SANJIA (CN)
WANG ZHIWEI (CN)
XU SANJIA (CN)
Application Number:
PCT/CN2020/102647
Publication Date:
January 28, 2021
Filing Date:
July 17, 2020
Export Citation:
Assignee:
BEIGENE LTD (KY)
LI JING (CN)
LI JING (CN)
International Classes:
C07D471/04; A61K31/407; A61P35/00; C07D471/02
Domestic Patent References:
| WO2014093383A1 | 2014-06-19 | |||
| WO2008124849A2 | 2008-10-16 | |||
| WO2016164641A1 | 2016-10-13 |
Foreign References:
| CN109923114A | 2019-06-21 |
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF: